Israel's Gamida Cell gets buyout offer from unnamed drugmaker

[riky]

Israel's Gamida Cell gets buyout offer from unnamed drugmaker

Israeli developer of stem cell therapies Gamida Cell has received a buyout offer worth hundreds of millions dollars from an unnamed global pharmaceutical company, two shareholders in the company said on Tuesday. Elbit Medical Technologies, which has a 30.8 percent share in Gamida, said the offer includes a "significant immediate payment and additional future payments totaling hundreds of millions of dollars". Israel's Globes financial daily reported that the interested buyer was Swiss drugmaker Novartis, though a spokeswoman for Elbit said they were not commenting on the report. The offer was received on March 7, said Clal Biotechnology Industries, which has about 22 percent of Gamida, in its own statement to the Tel Aviv Stock Exchange.

Source: You are not allowed to view links. Register or Login